Breakfast and Industry Symposium 

Dr. Sidney Wallace and Dr. Michael J. Wallace Distinguished Lecture
Presented by Afshin Gangi, MD, PhD

HCC Tumor Board (200 Level Education)
Moderated by Sarah White, MD, MS, FSIR, and Beau Toskich, MD

• Laura Crocetti, MD, PhD, EBIR
• Alessandro Vitale, MD
• Amit Singal, MD
• Riad Salem, MD, MBA
• Jin Woo Choi, MD, PhD
• Pretesh R. Patel, MD

Critical Studies (200 Level Education)
Moderated by Edward Kim, MD, FSIR, Terence P. Gade, MD, PhD, and Philippe L. Pereira, MD

• RETNET: Driving a Study to Completion and Implications, presented by Michael C. Soulen, MD, FSIR, FCIRSE
• ACCLAIM: Where Are We? presented by Constantinos (Costi) Sofocleous, MD, PhD, FSIR, FCIRSE
• CHOPIN: Closing Out a Study and Findings, presented by Mark Burgmans, MD
• COVERALL: Delivering a Study with Difficult Concepts, presented by Bruno C. Odisio, MD, PhD, FSIR
• Cryoablation in Metastatic Melanoma: Development and Findings in a Fundamental Study, presented by Florian J. Fintelmann, MD
• ENFORCE: What to Test and How in Prostate Cancer, presented by Jurgen Futterer, MD, PhD
• Emerald Pipeline: 1/3/Y90, presented by Joseph Erinjeri, MD, PhD

GU Session (200 Level Education)
Moderated by Vijay Ramalingam, MD, FSIR, and David Woodrum, MD, PhD

• Prostate Cancer: Treatment Decision Making, presented by Timothy D. McClure, MD
• Anatomic Considerations in Focal Treatment, presented by Guilherme Mariotti, MD, MSc, PhD, MBA
• Focal Treatment in Prostate: The Best Way to Do It, presented by David Woodrum, MD, PhD
• Renal Cancer Ablation: What is the Current Place of Ablation and Have We Agreed a Standardized Procedure? presented by Thomas D. Atwell, MD
• Roundtable Discussion: Challenging Cases, facilitated by Alex King, MBBS, FRCR, and Vijay Ramalingam, MD, FSIR

y90 Dosimetry & Hands-on Workshop

• Introductory Lectures, moderated by Irene Bargellini, MD
• y90 Dosimetry Made Easy: What IRs Need to Know, presented by Marnix Lam, MD, PhD
• y90 Dosimetry: Current Guidelines in Primary Liver Lesions, presented by Nora Elizabeth Tabori, MD
• y90 Dosimetry: Current Guidelines in Liver Metastases, presented by Ammar Sarwar, MD FSIR
• The Importance of Spheres' Concentration and Distribution: presented by Tyler Sandow, MD
• Case 1: Radiation Segmentectomy, presented by Siddharth A. Padia, MD
• Case 2: Radiation Lobectomy, presented by Zachary Berman, MD
• Case 3: Multifocal Liver Mets, presented by Roberto Iezzi, MD, FCIRSE

Exhibit Hall Networking

Discovery Theater

• Publishing in Interventional Oncology 
  Moderated by Michael C. Soulen, MD, FSIR, FCIRSE and Riad Salem, MD, MBA 

  • Publishing in the IO Space: The View from CVIR Oncology, Thomas Helmberger, MD 

  • Publishing in the IO Space: How Should SIO Proceed?, Daniel Sze, MD, PhD 

  • Discussion 

• Industry Product Theatre

Grants Session (300 Level Education)
Moderated by Terence P. Gade, MD, PhD, Julius Chapiro, MD, PhD, and Christopher D. Malone, MD

• Welcome and SIO Grant Program Introduction, presented by Terence P. Gade, MD, PhD
• Understanding the Influence of Hepatocellular Carcinoma Tumor Immune Microenvironment on Response to y-90 Radioembolization and Potential Combinations with Immune Checkpoint Inhibition, presented by Christopher D. Malone, MD
• Spatial Proteogenomics for Prediction of Response in Combined Radioembolization and Immunotherapy of HCC
• Discussion

SIO Meets SITC: Beyond Liver (300 Level Education) 
Moderated by Rony Avritscher, MD, and Tulia C. Bruno, PhD

• IO's Role in the Development and Application of Antitumoral Vaccines
• Immunoscoring and TLCs as a Biomarker of Response to Local Therapy
• Biomechanical Issues in Intratumoral Interventions
• Lessons Learned from Melanoma to RCC Therapy?
• IO Approaches to Overcoming Barriers in CAR-T Cell Delivery

OMD Tumor Board [Non-Hepatic] (200 Level Education)
Moderated by Alexis Kelekis, MD, PhD, EBIR, FCIRSE, FSIR, and David Breen, MD, FRCR

• Alda Tam, MD
• Robert Liddell, MD
• Alexandra Hotca-Cho, MD
• Dimitrios Filippiadis, MD, PhD, MSc, EBIR
• Michael Rutenberg, MD, PhD

Emerging Non-Thermal Ablation: Clinical Applications (300 Level Education)
Moderated by Paul Laeseke, MD, PhD, and Marwan Moussa, MD

• Limitations of Thermal Ablation, presented by Erica Knavel Koepsel, MD
• IRE: Role in the Liver, presented by Man-Deuk Kim, MD, PhD, FSIR
• Current Status, Data, and Limitations of Histotripsy, presented by Mishal Mendiratta-Lala, MD
• Electrochemotherapy in Palliation, presented by Frederic Deschamps, MD
• PEF in Advanced Lung Cancer: Where are We? presented by William Moore, MD

Scientific Oral Abstracts (200 Level Education)

Locally Advanced Pancreatic Cancer: Adding the Local Approach (300 Level Education)
Presented by William Rilling, MD, FSIR, and Govindarajan Narayanan, MD

• State of the Art Optimal Chemotherapy [mFolfirinox / Gem-nabPac] and Radiotherapy Consolidation presented by Michael J. Overman, MD
• Understanding the Difficult TME of LAPC, presented by Nadine Abi-Jaoudeh, MD
• IRE, Panfire-2 and Crossfire: What Have We Learned? presented by Hester J. Scheffer, MD
• Emerging Locoregional Technologies and Energies, presented by Martijn R. Meijerink, MD, PhD, FCIRSE
• Adjunctive Intra-arterial Approaches, presented by Paula Novelli, MD, FSIR

Industry Product Theater

Metastatic Liver Session: mCRC and mNET (200 Level Education)
Moderated by Nicholas Fidelman, MD, and Constantinos (Costi) Sofocleous, MD, PhD, FSIR, FCIRSE

• mNET: Current Role of y90? presented by Ghassan El-Haddad, MD
• mNET: LDT for Grade 3 Disease, presented by Nicholas Fidelman, MD
• Assessment of FLR Function: How? presented by David C. Madoff, MD
• Optimal Strategies for Venous Deprivation? presented by Jose Hugo Luz, MD, PhD, SOBRICE, FCIRSE
• In Light of COLLISION: Optimal Approach to Bilobar Disease - IR Perspective, presented by Martijn R. Meijerink, MD, PhD, FCIRSE
• In Light of COLLISION: Optimal Approach to Bilobar Disease - Surgeons Perspective Cases, presented by Nicholas Fidelman, MD, and Constantinos (Costi) Sofocleous, MD, PhD, FSIR, FCIRSE

• Critical Role of Surgical Oncology, presented by Matthew Goodwin, MD, PhD
• State of the Art Palliative Radiation and SBRT, presented byClifford G. Robinson, MD
• IR Role in the Multidisciplinary Treatment, presented by Matthew R. Callstrom, MD, PhD
• Multidisciplinary Tumor Board, moderated by Jack Jennings, MD, PhD, FACR, FSIR, FCIRSE, and Steven Yevich, MD, MPH, with Matt Goodwin, MD, PhD, Clifford G. Robinson, MD, and Matthew R. Callstrom, MD, PhD

Saturday Soiree Social Event*

Additional registration required

Private Practice Forum: New Arenas (200 Level Education)
Moderated by Jason R. Levy, MD, FSIR, and Juan Camacho, MD

• Business Case to Clients and Strategy for Building IO in the Hospital Based Setting, presented by Jason R. Levy, MD, FSIR
• Business Case for Building IO in an OBL Setting, presented by Charles W. Nutting, DO, FSIR
• Thyroid Ablation for Primary Thyroid Cancer, presented by Juan Camacho, MD
• Breast Cryoablation: Current Indications and Technical Updates and Payment Models, presented by Kenneth Tomkovich, MD
• Roundtable Discussion

Evidence-Based Illustrative Case Review (200 Level Education)
Moderated by Nicholas Fidelman, MD

• Case 1: Lymphatics, presented by Jinoo Kim, MD
• Case 2: Thyroid, presented by Wei-Che Lin, MD
• Case 3: Difficult mCRC, presented by Stephen Hunt, MTR, MD, PhD, FSIR
• Case 4: Adrenal, presented by Shamar J. Young, MD
• Case 5: Sarcoma / Soft Tissue, presented by Robert Luigi Cazzato, MD, PhD
• Case 6: Vascular Emergencies in IO, presented by Charles J. Kim, MD
• Case 7: T1b RCC, presented by AJ Gunn, MD